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Point mutations in bovine opsin can be classified in four groups with 
respect to their effect on the biosynthetic pathway of opsin
Godelieve L. J. DeCALUWÉ and Willem J. DeGRIP*
Department of Biochemistry F M W -1 6 0 , Institute of Cellular Signalling, University of Nijmegen, P .O . Box 9 1 0 1 , 6500 H B  Nijmegen, The Netherlands
Expression in vitro with the recombinant baculovirus expression location as well as glycosylation, which can be interpreted as
system showed correct biosynthesis and post-translational pro­
cessing of ‘wild-type’ bovine opsin with regard to translocation,
interference with the function of a transfer signal. Substitutions 
at positions Glu-113, Glu-122, Glu-134, Arg-135 and Lys-248
glycosylation, palmitoylation and targeting. However, several of belong to this category. A fourth group induced structural
these processes were severely affected by point mutations. From  
the overall results of 16 mutants reported here, four groups were 
distinguished. One group significantly affected neither bio­
synthesis nor folding of opsin (D83N, P291A, A299C-V300A- 
P303G). A second group produced a truncated protein (R69H, 
Y301F), suggesting that these positions are essential for a correct 
translational process. A third group affected membrane trans­
changes in the protein that led to heterogeneous distribution in 
the plasma membrane (E113Q/D, W265F, Y268S). Taking any 
functional consequences of these mutations into consideration, it 
seems that point mutations can have mosaic effects and therefore 
should be examined at several levels (folding, targeting, functional 
parameters).
IN TR O D U C TIO N
Rhodopsin is a complex integral membrane protein containing 
seven transmembrane domains, which harbour the chromophore 
11-as retinal covalently linked to Lys-296 via a protonated Schiff 
base [1]. The N-terminal region is glycosylated [2] and. is of 
structural importance, together with the three intradiscal loops 
and the disulphide bridge between Cys-110 and Cys-187 [3,4]. 
Two cytosolic loops are thought to play a role in signal 
transduction [5] together with an additional surface loop 
generated by palmitoylation and membrane anchoring at Cys- 
322 and Cys-323 [6] (Figure 1). Evidently, rhodopsin requires 
intermittent membrane translocation and several post- 
translational modifications (glycosylation, palmitoylation, di­
sulphide bridge formation, recombination with ll-cw-retinal) to 
fulfil all its structural and functional properties. Expression in 
vitro permits the exploration of properties such as wavelength 
regulation, receptor mechanism, biosynthesis and lipid-protein 
interactions in much detail through (site-specific) mutagenesis. 
For this purpose we have selected the recombinant Autographa 
calif ornica nuclear polyhedrosis virus (AcNPV)-baculovirus sys­
tem, as this is a eukaryotic expression system that performs all 
common eukaryotic post-translational modifications and has
influence of a panel of mutations on selected positions (Figure 1) 
on this process. For this panel we have selected highly conserved 
amino acid residues, that are located in the transmembrane or 
interface regions, where effects on functional properties have 
been described and effects on biosynthesis and folding are 
indicated or might be expected. In this context we do not address 
functional properties such as the activation o f transducin, but for 
most of the mutations described such parameters have been 
reported elsewhere.
We reported before that the mutation El 34D, shown earlier to 
affect transducin activation [16,17], also affects rhodopsin bio­
synthesis in that a larger proportion of non-glycosylated product 
was generated and indirect evidence was obtained for incorrect 
folding of part o f  the protein population [18,19]. Our hypothesis 
is that Glu-134 is part o f  a stop-transfer signal, which shows slip 
when mutated. This would lead to incorrect folding of part of the 
total opsin population. Here we investigate these aspects further, 
along the following lines. We have identified several residues that 
affect functional as well as biosynthetic regulators of the protein, 
showing that this is not an isolated phenomenon. These results 
further support the concept that critically positioned polar 
residues contribute significantly to stop/start-transfer signals, 
whereas structurally important non-polar residues are less es-
been successfully employed for the high-level expression of sential in this respect. To demonstrate this we concentrate here
heterologous proteins (reviewed in [7,8]).
Bovine rhodopsin and its mutants have been expressed in vitro 
in many different systems: COS cell lines [9], insect cell lines with 
the use of recombinant baculovirus [10], Xenopus oocytes [11], 
human embryonic kidney cell line [12], the Chinese hamster
on several highly conserved polar (Arg, Lys, Glu, Asp) or 
structural (Tyr, Trp, Pro) residues in or near the second, third, 
sixth and seventh membrane domains (Figure 1). In two cases 
several mutations were analysed to address possible charge
effects (E134D/R, E134R-R135E) or any direct relation with
ovary cell line [13] and a cell-free expression system [14]. Usually functional effects (El 13D /Q /Y /C ).
the effect of mutations on functional properties is examined; 
possible underlying effects on the level of biosynthesis and 
folding are rarely investigated. Here we examine the biosynthesis
The picture emerges that the rhodopsin sequence is dclicately 
tuned to correct membrane translocation and folding. A variety 
of substitutions affect this process to a variable extent, and some
of opsin in insect cells under the control of the baculovirus mutations even have an effect at an earlier stage and seem to 
polyhedrin promoter in more detail [15], and investigate the abort the translational process.
Abbreviations used: AcNPV, Autographa calif ornica nuclear polyhedrosis virus; DoM, dodecyl /M-maitoside; dpi, days post-infection; TM, 
transmembrane domain; v-ops, opsin produced in insect cells by recombinant baculovirus.
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Figure 1 Model of the topography of rhodopsin [59]
The amino acids replaced in the present work are indicated in black. Abbreviation: Th, thermolysin proteolytic recognition site [44],
E X P E R I M E N T A L  infection with recombinant virus. Cells were harvested at 3 dpi,
„ , , . . . . . . .  . lysed by freeze-thawing twice in distilled water with the addition
Baculovirus expression, site-directed mutagenesis, S D S / P A G E , Ieupeptin (200/,M ; Sigma) and EDTA (lOmM) , sedimented
immunoblotllng, E L I S A  and the immunofluorescence assay by '(Eppe„dorf; 17000 g for 5 min at room tem-
These were performed as described [10,18,20-22]. For molecular perature), and the precipitate was resuspended in buffer A
[20 mM P ipes/130 mM NaCl/5 mM KC1/2 mM MgCla/2  mM 
CaCl2/0.1 mM EDTA/5m M  1,4-dithioerythritol (pH 6.5)].
Then dodecyl /?-l-maltoside (DoM) was added to a final con­
centration of 20 mM and the suspension was rotated overnight 
at 4 °C. The resulting DoM extract was used for immuno­
précipitation of opsin produced in insect cells by recombinant 
baculovirus (v-ops).
mass calibration a low-molecular-mass protein electrophoresis 
calibration kit (Pharmacia) was used, containing phosphorylase 
b (94 kDa), BSA (67 kDa), ovalbumin (43 kDa), carbonic 
anhydrase (30 kDa), soybean trypsin inhibitor (20.1 kDa) and 
a-lactalbumin (14.4 kDa).
Some aspects, relevant to the present study, are explained here 
in more detail. IPLB-Sf9 cells were cultured on glass coverslips 
(immunofluorescence analysis) or in monolayer culture (1-2 ml; 
Gibco 6-12-well plates; all other analyses). Infection with 
baculovirus was performed at a density of 10° cells/ml and a 
multiplicity of infection of 10. Immunofluorescence analysis was 
performed at 2 days post-infection (dpi) because as the infection 
proceeded the cells tended to dissociate from the glass substrate. 
Although dissociated cells were still viable and impermeable to 
Trypan Blue, only attached cells were used for the analysis. The 
other studies were performed on attached cells at 3 dpi. At this 
stage over 95 % of the cells were still viable as assessed by Trypan 
Blue exclusion, irrespective o f the type of recombinant virus 
used. As reported before, in our hands at a multiplicity of 
infection of 10 or less, significant cell death does not occur until
5 dpi [15]. Even at that stage, attached cells are still viable. 
Because non-viable cells detach from the substrate, all analyses 
were performed on a cell population o f which less than 1 % was 
permeable to Trypan Blue or to the antibodies used. This 
excluded the possibility that the results presented were influenced 
by variability in the initial permeability of the cells.
Immunoprécipitation
Protein A-agarose (10 /¿I; Pierce) was loaded with the anti- 
rhodopsin antibody [23] CERNJS858 (10 /¿l) by rotation over­
night at 4 °C in 0.5 ml of buffer A containing 20 mM DoM. 
Unbound material was removed by several steps of centrifugation 
(Eppendorf; 500 g for 5 min at 4 °C) and washing (buffer 
A/20 mM DoM). The DoM extract described above was freed 
from insoluble material by centrifugation (Eppendorf; 17000 g  
for 15 min at 4 °C), applied to Protein A-agarose loaded with 
CERNJS858 (100 /¿1/10 /à of gel) and rotated overnight at 4 °C. 
Unbound material was removed by centrifugation (Eppendorf; 
500 g for 5 min at 4 °C), followed by two washing steps (0.5 ml 
of buffer A /20  mM DoM) and elution of bound material in 
SDS/PAGE sample buffer [4% (w/v) SD S/15m M  Tris/HCl 
(pH 6.8)/10%  (v/v) glycerol/0.006 % Bromophenol Blue/
20 mM dithioerythritol; 100 /¿I/10 /¿I of gel].
Palmitoylatlon Digestion by thermolysin
Sf9 cells were incubated with [ l-14C]palmitic acid (1 /iCi/10° Sf9 cells were infected with recombinant virus and collected at 
cells; specific radioactivity 50-60 mCi/mmol; Amersham) during 3 dpi by centrifugation (1000 g  for 5 min at room temperature).
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Lysed cells (prepared as above) and intact cells were gently 
resuspended in thermolysin digestion buffer [10 mM Tris/acetate 
(pH 7.2)/4 mM CaCl2/ 10 % thermolysin (w/w on protein basis);
50 //I per 10° cells] and incubated for 5 min at room temperature. 
Under these conditions, although intact cells slowly became 
permeable to the enzyme, less than 25% of wild-type opsin in 
intact cells became susceptible to proteolysis, whereas over 90 % 
of the opsin in lysed cells was cleaved by the protease. Subse­
quently the reaction was stopped by the addition of EDTA 
solution (0.5 M, pH 8) to a final EDTA concentration of 0.2 M. 
Intact cells were then lysed and SDS/PAGE samples (150 /d per 
10“ cells) were prepared by the addition of SDS/PAGE sample 
buffer (for final concentrations see above).
Quantification
Opsin bands on immunoblots and autoradiograms were quanti­
fied with an imaging densitometer (Model GS-670; Bio-Rad) 
combined with Molecular Analyst Software for image analysis. 
For determination of the extent of palmitoylation, monomer 
opsin bands were used, as oligomers are artifacts of the SDS/ 
PAGE analysis. Because expression levels also varied, the amount 
of monomeric opsin varied strongly per lane. Therefore the 
palmitoylation signal on the autoradiogram was normalized to 
the same amount of opsin by dividing by the monomeric band 
signal on a parallel Coomassie Blue-stained gel or immunoblot.
For quantification of proteolysis, two controls were incor­
porated. For all three conditions (intact cells without proteolysis, 
intact cells with proteolysis, or lysed cells with proteolysis) 
extracts of the same numbers of cells were applied on two parallel 
SDS/polyacrylamide gels. One gel (A) was immunoblotted with 
the polyclonal antiserum CERNJS858, the other (B) with the 
monoclonal antibody 1D4 [24], which recognizes residues 341- 
348 of opsin. Hence the two proteolytic products o f opsin (1-327 
and 1—336), which migrate just below the intact protein, appear 
in A but not in B. The combined monomeric bands (intact and 
fragments) should represent about the same amount of protein 
under the three conditions. Experiments were therefore accepted 
only if the combined intensity in A did not vary between the three 
conditions by more than 10%. The intensity of the monomeric 
bands in B was used to determine the extent of proteolysis. Here, 
with the intensity in the intact cells without enzyme (1) set at
the intensity in the lysed cells treated with enzyme (3)100%,
should be less than 10%. With all requirements met, the ratio 
between the band intensity in the intact cells treated with enzyme 
(2) and that in (1) presented a semi-quantitative measure of the 
percentage of protein accessible to proteolysis.
R E S U L T S  
In com plete tra n slatio n
Two of the mutations investigated, R69H and Y301F, produced 
very little intact protein, but mainly truncated products of 
approx. 22 and 30 kDa respectively (Figure 2, lanes 1 and 15; 
Table 1). This pattern was identical in cells analysed earlier after 
infection (1 and 2 dpi). Both products still contained the N- 
terminus and the extracellular loop e2 but lacked the C-terminus 
(Figures 2 and 3). These mutants also produced bands that were 
less discrete, indicating that these two mutations induced aberrant 
interruption and abortion of the translational process. The 
truncated products had a much stronger tendency to aggregate in 
SDS solution than did the intact protein (Figure 2, lanes 1 and 
15; Figure 3, lane 5).
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Figure 2 Effect of selected mutations on v-ops glycosylation
Immunoblot analysis of opsin mutants, produced in Sf9 cells with the corresponding 
recombinant mutant opsin virus. Opsin was identified by incubation with antiserum CERNJS858 
(A) or 1D4 (B). Lane 1, R69H; lane 2, D83N; lane 3, E113Q; lane 4, E113D; lane 5, E113Y; 
lane 6, E113C; lane 7, E122L; lane 8, E134D; lane 9, E134R; lane 10, E134R-R135E; lane 
11, K248L; lane 12, W265F; lane 13, Y268S; lane 14, P291A; lane 15, Y301F; lane 16, 
A299C-V300A-P303G. The loading per lane was the extract of 2 x  1 04 cells (lane 7), 4 x  1O'* 
cells (lanes 2, 5, 6, 8 and 11), 105 cells (lanes 1, 9 ,1 2 .1 3 ,  14 and 16) and 2 x  105 cells 
(lanes 3 ,4 ,1 0  and 15). The positions of glycosylated (arrow) and non-glycosylated (arrowhead) 
opsin are indicated. The positions of molecular mass markers (kD, kDa) are shown at the left.
Glycosylation
Previously we demonstrated that v-ops migrates on SDS/PAGE 
gels with about the same apparent molecular mass as fully 
processed native bovine rod opsin [15]. A positive immuno- 
reaction with monoclonal antibodies against the N-terminus 
(R2-12N), loop e2 (T13-34L) [25] and the C-terminus (1D4) [24] 
indicates that the full-length protein is produced (Figure 3). That 
v-ops is glycosylated was confirmed by adding the N- 
glycosylation inhibitor tunicamycin on infection o f Sf9 cells with 
recombinant virus. The resulting product still contained the 
complete opsin sequence [18] but migrated with a lower apparent 
molecular mass [15], corresponding to that of non-glycosylated 
native rhodopsin. Under high-resolution conditions the 
glycosylated v-ops seemed to consist of two Three
different recombinant viruses producing wild-type opsin, con­
structed with different transfer vectors, produced the glycosylated 
species with no detectable or very low levels of non-glycosylated 
product (less than 10%; Table 1). Several of the amino acid
substitutions reported here affected opsin glycosylation to a 
much larger extent (Figure 2). First, the ratio between the upper 
and lower glycosylated bands (arrow) showed considerable 
variation. However, this depended partly on cellular factors, 
because some variation was also observed within different batches 
of one mutant. Hence it is currently not clear whether a mutation- 
dependent effect also operates here. Secondly, a number of 
mutations clearly enhance the relative amount of non- 
glycosylated product (Figure 2, arrowhead, E113C/Y; E122L; 
E134D/R; K.248L). This pattern was reproduced in at least three
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Table 1 Biosynthesis of opsin and selected mutant species in Sf9 cells 
infected with corresponding recombinant virus
The pAc transfer vector used is shown in parentheses in the first column. The expression level 
was measured by inhibition ELISA and/or by immunoblot analysis. The molecular masses 
shown are the apparent molecular masses by SDS/PAGE; 38 kDa represents the glycosylated 
and 31 kDa the non-glycosylated intact protein; 30 and 22 kDa represent a glycosylated but 
truncated protein, The ratings in parentheses In the third column indicate the amount of non- 
glycosylated as a percentage of total species; + ,  less than 10%; + ,  2 0 -3 0 % ; +  + ,  
3 0 -4 0 % ; +  +- + ,  4 0 -6 0 % , determined by densitometer imaging of immunoblots analysed 
with CERNJS858.
A B
Molecular 
mass of
Species
Expression level 
(pmol/106 cells)
produces)
(kDa)
Wild-type (373) 2 0 -2 5 38
Wild-type (RP23) 2 0 -2 5 38
Wild-type (DZ1) 3 0 -3 5 38, 3 1 ( ± ) ‘
R69H (DZ1) 2 5 -3 0 22
D83N (RP23) 2 5 -3 5 38
E113Q (D21) 1 0 -1 5 38
E113D (DZ1) 1 0 -1 5 38
E113Y (DZ1) 1 5 -2 5 38, 31 ( +  )
E113C (DZ1) 1 5 -2 5 38, 31 ( +  )
E122L (DZ1) 2 5 -3 5 38, 31 ( H— I— H )
E134D (RP23) 30—40 38, 31 ( 4- H- )
E134R (DZ1) 2 0 -3 0 38, 31 ( "I* )
E134R/R135E (DZ1) 1 0 -2 0 38, 31 ( +  )
K248L (RP23) 35—45 38, 31 ( ”1" H- )
W 265F (DZ1) 1 0 -1 5 38
Y268S (DZ1 ) 1 5 -2 0 38
P291A (RP23) 1 5 -2 0 38
Y301F (DZ1) 5 -1 0 30
A299C/V300A/P303G (RP23) 1 5 -2 0 38
c D
Figure 3 Product analysis of selected v-ops mutants with a panel of 
antibodies
Immunoblot analysis of Sf9 cells infected with wild-type (AcNPVDZI /ops) and recombinant 
mutant opsin virus. Lane 1, v-ops; lane 2, E134D; lane 3, E134R; lane 4, E134R-R135E; lane 
5, R69H; lane 6, K248L; lane R, bovine ROS membranes. Opsin was identified by incubation 
with (A) polyclonal"ln'ïï§@'fUm CERWJS858■; (B) monoclonal antiserum R2-12N-against the N- 
terminus; (C) monoclonal antiserum T13-34L against loop e2; (D) monoclonal antiserum 1D4 
against the C-terminus. Each lane contained the extract of 5 x  104 cells. The positions of 
glycosylated (arrow) and non-glycosylated (arrowhead) opsin are indicated. The positions 
of molecular mass markers (kD, kDa) are shown at the left.
experiments (Table 1). These non-glycosylated products do 
contain the full protein sequence because they all reacted with 
the C-terminal monoclonal antibody 1D4 (Figure 2B). The 
strongest effects were seen for E122L, K248L and E134D, 
Remarkably the production of non-glycosylated species varied 
lor different mutations on one site (El 13C >  E 113Y > El I3Q 
=» El 13D; E134D > E134R). No interference with glycosylation 
was observed with the other mutants described here (Figure 2): 
D83N (lane 2), El 13Q (lane 3), El 13D (lane 4), W265F (lane 12), 
Y 268S  (lane 13), P291A (lane 14) and A299C-V300A-P303G
(lane 16). Expression levels and apparent molecular masses of the 
synthesized v-ops and mutant products are listed in Table 1. All 
mutants were expressed at average or below average levels and 
we conclude that the interference with glycosylation is due to the 
mutation, as already previously inferred for El 34 mutants [18]. 
In addition, the mutations E113Q/D, E134R-R135Eand W265F
significantly decreased the expression level, indicating that these 
amino acid substitutions do affect the translation efficiency in 
this system.
P a lm ito y la tio n
Because insect cells are able to sustain thiopalmitoylation [26], 
we also examined whether v-ops and selected mutants were 
palmitoylated. Sf9 cells were incubated with [,4C]palmitic acid 
during infection with recombinant virus. Opsin was then 
solubilized with DoM, immunoprecipitated with CERNJS858 
and, after SDS/PAGE, the opsin band was identified by immuno- 
blol and palmitoylation was identified by autoradiography. Both 
bands were quantified by densitometer imaging and the extent
of palmitoylation was normalized with respect to the amount 
of protein in the same band, to permit a comparison o f  
palmitoylation levels in wild-type and mutant proteins. A large 
population of proteins in infected cells was palmitoylated under 
these conditions (results not shown). Opsin was. isolated by 
immunoprécipitation and clearly displayed label incorporation 
(Figure 4, lane 1). The label was quantitatively removed by
incubation with hydroxylamine [1 M hydroxylamine/1 0 BSA/
PBS (pH 7.5) for 4 h at 37 °C], demonstrating lhat it was bound 
as a palmitoyl thioester [27]. Hence opsin was also palmitoylated 
in this expression system.
For all mutants investigated the intact glycosylated form 
behaved comparably to its wild-type equivalent: it was 
palmitoylated and was easily solubilized and immunoprecipitated 
from detergent solution (Figure 4). The extent of palmitoylation 
of glycosylated mutant opsins was estimated relative to the wild 
type by densitometer imaging of the immunoprecipitated bands 
on immunoblot and on the corresponding autoradiogram. All 
mutants showed a palmitoylation level within 30 % of the wild- 
type level, which is within the error range of this complex 
analysis, and hence should be considered normal, except for 
D83N and W265F, in which the extent o f palmitoylation was 
decreased to respectively 35+ 10% and 21 ±15%  of the wild- 
type level (values given ±S.D .).
Membrane translocation and targeting
As we have shown previously by immunocytochemical analysis 
[10,15], bovine opsin produced in-Sf9 cells is. targeted to the
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Table 2 Immunohistochemical analysis of wild-type rhodopsin folding by 
monitoring the reactivity of monoclonal antibodies with intact and fixed Sf9 
cells infected with recombinant opsin bacuiovirus
Immunoreactivity was detected by reaction with fluorescein-conjugated second antibodies, and
is rated from — (negative: signal not above background) to +  +  -t- (very strong positive 
reaction).
Antibody
Intact
cells
Fixed
cells
R2-12N (N-terminus) 
T13-34L (loop e2) 
K42-41L (loop ¡3)
1D4 (C-terminus)
858 (polyclonal)
+  +
—n| h i
H* ■+■ H- 
+
~f~ +
~ f *  +  H- 
*+■ 4* +
* •
Figure 4 Palmltoylatlon of mutant opsins
Autoradiographic analysis of immunoprecipilated wild-type and mutant opsins. Sf9 cells were 
irifodod willi recombinant virus in the presence of labelled [,4C]palmitic acid. Lane 1, v-ops; 
lane K ?48t; lane 3, E134R; lane 4, E134D; lane 5, E134R-R135E; lane 6, E113C;'lane 7 ,  
E113D; Ian« 8. E113Q; lane 9, E113Y; lane 10, D83N; lane 11, W265F. Each lane contained 
tho imimmoprecipilated fraction of approx. 8 x  105 cells. R shows the position of glycosylated 
rhodopsin from bovine ROS membranes as detected by Coomassie R-250 and subsequent 
silver-staining of the SDS/PAGE gel. The positions of molecular mass markers (kD, kDa) are 
shown at the lelt.
Figure 5 Mutant opsins are also targeted to the plasma membrane
Iniliriu'.l immunofluorescence assay of Sf9 cells infected with recombinant wild-type 
(AcNPVD /l/ops) (A) or E113Q mutant (B) opsin virus. After fixation at 2 dpi, opsin was 
Ux:ali/n<t with tho polyclonal antiserum CERNJS858. Immunoreactivity was detected by reaction 
with llunrtfficiiin cunlugated goat anti-rabbit IgG. The mutants E113D, E113Y, E113C, W265F 
anil YWitlS display a similar palch-like distribution pattern to that shown for E113Q (B). Scale 
liar. 1 / /n i.
Table 3 Membrane translocation of wild-type and mutant opsins analysed 
by double-label indirect immunofluorescence analysis (IFA) of intact cells 
and immunoblot analysis of intact thermolysin-treated cells
The immunohistochemical reactivity of rhodopsin monoclonal antibodies against the N-terminus 
(R2-12N) and C-terminus (104) on intact Sf9 cells infected with recombinant opsin or mutant 
virus was detected by reaction with fluorescein-conjugated goat anti-mouse IgG. Total reactivity 
was determined after fixation with the polyclonal antiserum CERNJS858 and rhodamine- 
conjugated pig anti-rabbit IgG. Immunoblot analysis of intact Sf9 cells after infection with 
recombinant virus and incubation with thermolysin was performed as described in Figure 6. 
Immunoreactivity (IFA) was rated as: - ,  less than 10%; +  , 20-30% ; +  +  , 40 -60% ;  
+  +  +  , 70-80% ; +  +  +  + ,  more than 90%, measured by the number of reactive cells 
relative to total reactivity with the polyclonal antiserum CERNJS858 after fixation. Thermolysin 
digestion is rated as: — , less than 25%; + ,  25-50% ; +  + .  50% or more, measured by 
digestion of the glycosylated (Glyc) or non-glycosylated (Nglyc) forms, In intact cells after 5 min 
of incubation with thermolysin. Abbreviations: n.a., not applicable; n.d., Nglyc not detectable.
Opsin species
IFA Thermolysin digestion
R2-12N 1D4 Glyc Nglyc
Wild-type +  +  +  + — —
R69H +  +  +  + — n.a. n.d.
D83N +  +  +  + — — n.d.
E113Q +  +  +  + + + + n.d.
E113D +  +  + +  + + n.d.
E113Y +  +  +  + +  +  +  + +
E113C +  +  +  + + + +  + +
E122L +  +  +  + + + +  + —
E134D •b +  + “f" - f —
E134R +  +  + _J- _j-
E134R/R135E +  + H— b +  + +  +
K248L nijwi -- +  + + —
W265F +  +  + + — n.d.
Y268S “h +  "f -h — — n.d.
P291A +  +  + + — n.d.
Y301F + — n.a. n.d.
A299C/V300A/P303G 4- ■+■ +  + — — n.d.
plasma membrane (Figure 5A). Because the opsin recombines to
a largo extent with added l l - m  retinal into rhodopsin it was
assumed that this complex membrane protein had been correctly
translocated and folded in the endoplasmic reticulum membrane
of the Slx.) cell. However, this cannot be assumed for mutant
proteins because the mutation might impair translocation and/or 
folding without affecting targeting. A dual assay to probe for of the cells by mild fixation should the latter epitopes become
k y  J  L 4  •  •  -4 * 1 1  i  i  •  1  _ .1  *  ^  T \  ^  ^  ^  1  I A  j J  ^  n  A  4 *  A  * •  A  A  m l  4» / S
correct translocation was developed, by using (1) limited pro­
teolysis of intact or lysed cells and (2) immunofluorescence 
analysis of both intact and permeabilized cells with monoclonal 
antibodies directed against epitopes distributed over the opsin 
sequence [24,25]: antibodies against the N-terminal domain (R2- 
12N) and loop e2 (T13-34L) recognize extracellularly located 
sequences in correctly folded opsin. Antibodies against the C- 
tenninal domain ( 1D4) or loop i3 (K42-41L) recognize sequences 
that should be located intracellularly. Only after permeabilization
accessible to antibodies. Because cells dissociate from the surface 
on or after 3 dpi, immunohistochemical analysis was performed 
at 2 dpi and the polyclonal antiserum CERNJS858 was used to 
estimate the relative number of positive cells and their average 
reactivity. This approach was tested on Sf9 cells producing wild- 
type opsin; the expected results were obtained (Table 2): epitopes 
that should have been located intracellularly became accessible 
only after permeabilization of the cells. From these results we 
conclude that Sf9 cells accomplish correct membrane insertion
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Figure 6 Analysis of incorrect translocation of mutant opsins by a short digestion of intact or permeabilized cells w ith  thermolysin
Immunoblot analysis of intact and lysed Sf9 cells Infected with recombinant wild-type or mutant opsin virus. R, bovine ROS membranes. Lanes 1 ,  total cell extracts of cells not incubated with 
thermolysin; lanes 2, total cell extracts of intact cells Incubated with thermolysin [10% (w/w) for 5 m in]; lanes 3, total cell extracts of lysed cells incubated with thermolysin. Opsin was identified 
with polyclonal antiserum CERNJS858 (A) or monoclonal antibody 1D4 (B). The positions of the intact glycosylated (arrow) and non-glycosylated (arrowhead) opsin are indicated. The positions
ol molecular nnass markers (kD, kDa) are shown at the left.
and targeting of the opsin sequence. Subsequently this approach 
was used to analyse the effect of mutations on membrane 
translocation and targeting. Again, Sf9 cells were infected with 
recombinant mutant opsin virus, and the immunofluorescent 
reactivity of intact cells with monoclonal antibodies against the 
N-terminal domain (R2-12N) and the C-terminal domain (1D4) 
was estimated, relative to the total immunofluorescent reactivity 
with CERNJS858 observed after permeabilization of the cells by 
fixation. The results are given in Table 3. This type of analysis 
shows that all mutants are targeted to the plasma membrane (see 
Figure 5), but quite a number of mutations show appreciable 
reactivity with 1D4 in intact cells. This could have been due to a 
complete reversal of the opsin disposition (N-terminus cytosolic,
lanes 3). Proteolysis was allow ed to  proceed until in permeabilized 
cells 1D4 reactivity had been largely abolished, as determined by 
immunoblot analysis. During this incubation, intact cells were 
slowly permeabilized but m ost (m ore than 75%) wild-type opsin 
remained protected against proteolysis because it retained 
immunoreactivity with 1D4 (T able 3 and Figure 6B; compare v- 
ops, lanes 1 and 2). Glycosylated and non-glycosylated bands on 
immunoblots were quantified by densitometer imaging and the 
degree of proteolysis was determ ined by converting the amounts 
o f intact protein to ratios (F igure 6B, lanes 2 to 1).
When applied to mutant opsins, the results support the 
immunofluorescence analysis. Because the immunofluorescence 
assay was more sensitive but m uch less quantifiable than the
C-terminus extracellular) or to incorrectly translocated opsin proteolytic approach, we com pare the two approaches quali-
tatively only. Mutations that resulted in a positive reaction with 
1D4 on intact cells showed a significant increase in susceptibility 
to proteolysis in intact cells (Table 3). For mutations that 
produced glycosylated as well as non-glycosylated species 
strong increase in immunolabelling intensity with 1D4 was not (E134D/R, E134R-R135E, K 248L ) the non-glycosylated forms
(both N- and C-termini extracellular). All available evidence 
supports the latter alternative. First, all cells in this group, 
inimunopositive for the C-terminally directed antibody, also 
reacted with the N-terminally directed antibody. Secondly, a
accompanied by a strong decrease for that with R2-12N. These sometimes seemed to be less susceptible on proteolysis of intact
results suggest strongly that the lD4-reactive mutant proteins cells (Table 3). Currently we interpret this lower susceptibility as
were produced by incorrect translocation across the endoplasmic being due to retention in intracellular compartments, because 
re t i c u 1 u m mem bra n e .
It seemed logical to assume that the non-glycosylated mutant
nearly complete proteolysis w as observed in permeabilized cells. 
Our results indicate that the described mutations of residues
form was responsible for this phenomenon. However, in con- Glu-113, Glu-122 and G lu-134 (third membrane domain) and
tradiction with this assumption is the fact that a number of Lys-248 (loop i3) enhanced the chance of incorrect translocation
mutant proteins did not produce detectable amounts of a non- of the opsin sequence, which w as also accompanied by a partial
glycosylated form but did react with 1D4 in intact cells (El 13Q, inhibition of glycosylation. T he m ost severe effects were observed
E113D, W265F). To distinguish between the glycosylated and with the mutations E134R and E134R-R135E, which produced
non-glycosylated species the following strategy was developed. only 30-40 % correctly folded glycosylated protein. This might
Sf9 cells were infected with recombinant virus and exposed after explain the low yields o f  regenerated pigment (5-10% of total
3 dpi to thermolysin digestion (Figure 6; thermolysin cleavage protein produced) obtained w ith  these mutants [22].
sites in bovine rhodopsin are indicated in Figure 1). In correctly Another remarkable observation  was made on some mutants
folded opsin these sites were only accessible in permeabilized (Glu-113 mutants, W 265F and Y268S) with the immuno-
cells, and proteolysis resulted in a shift to a lower molecular mass 
(Figure 6A, lanes 3) and a loss of reactivity with 1D4 (Figure 6B,
histochemical analysis. These mutants presented a different 
pattern from that observed for the wild type. Several cells
Biosynthesis oí bovine opsin mutants 813
showed a normal diffuse plasma membrane reaction, but other residues in transmembrane domains by Gly or Ala are generally
cells also showed a kind of spot-like pattern, possibly representing structurally well tolerated [33].
aggregated protein (Figure 5B). These spots were located in the Although Asp-83 is highly conserved among the entire family
plasma membrane because analysis o f  intact Sf9 cells showed the of G-protein-coupled receptors, replacement with Asn influences
same pattern with CERNJS858, and subsequent fixation and neither opsin biosynthesis or folding, nor has an effect been
incubation with 1D4 or R2-12N revealed no additional large observed on regeneration or transducin activation [20,34-37]. In
intracellular storage sites of opsin (results not shown).
D IS C U S S IO N
Apparently the biosynthesis, membrane translocation and 
glycosylation of opsin can be severely affected by point mutations. 
Only palmitoylation seems to occur fairly normally in most 
mutants described here. Hence the palmitoylation sites are 
apparently recognized and modified, whether located on the 
intracellular or the intraluminal side of the endoplasmic 
reticulum. Indeed, extracellular thiopalmitoylation sites have
retrospect this is not unexpected because the D83N mutation has 
meanwhile been detected in several rod visual pigments [38-41] 
and hence is unlikely to perturb the fine tuning of the protein 
sequence for correct biosynthetic processing. This seems to be in 
contrast with adrenergic receptors, where replacement with 
Ala/Arg affected the affinity for agonists and activation of the G- 
protein [42,43].
Type B : amino acid substitutions that result In the production of 
a truncated protein
been described in plasma membrane proteins [28], suggesting To this category belong R69H and Y301F. Interestingly, the
that thiopalmitoyl modification o f Cys residues can occur inside resulting incomplete protein was transferred to the plasma
the lumen of the endoplasmic reticulum. However, replacement membrane and the N-terminus was correctly located extra-
of Asp-83 with Asn or Trp-265 with Phe decreased the extent of cellularly. Hence, as expected, the first translocation-start signal
palmitoylation. This is currently unexplained.
It should be noted that our observations stem from hetero­
logous expression in insect cell lines that perform all essential 
eukaryotic protein processing but still differ in some aspects from translation and translocation probably proceed normally until
was properly recognized. However, the cause of the eventual 
truncation was probably different. The Y301F mutant produces 
a protein of approx. 30 kDa that lacks the C-terminus. Hence
the mammalian environment, from which these proteins orig­
inate. Nevertheless we do not consider this to have a major 
influence. Indeed, wild-type opsin is fully processed in these 
insect cells up to quite high expression rates (10-15 pmol/day per 
10" cells, which is comparable to a photoreceptor cell). Definite 
proof that the effects of point mutations that we observed also 
operate in the photoreceptor cell will have to come from studies 
with transgenic mice.
From the overall results we can distinguish four types of 
mutant, types A to D.
Type A :  amino acid substitutions that do not significantly affect 
opsin biosynthesis and folding of opsin
In this category are D83N, A299C-V300A-P303G and P291A. 
The presence of a Pro residue in a transmembrane domain is 
usually considered to be of structural importance [29,30]. 
Although Pro-291 is not generally conserved in the G-protein- 
coupled receptor family, it is fully conserved in the vertebrate 
visual pigments. Nevertheless the P291A mutation shows few 
structural consequences. This also agrees with our observation 
that this mutant shows normal regeneration capacities and 
spectral properties [22].
Pro-303 is fully conserved in the G-protein-coupled receptor 
family, but its replacement with Gly does not affect the bio­
synthesis of opsin. Spectral properties of rhodopsin are not 
a fleeted either [22]. However, transducin activation needs to be 
examined because replacement o f this residue in the m3 receptor 
with A la increased the affinity for agonists but severely impaired 
stimulation of Ptdlns hydrolysis. It might therefore represent a 
key residue involved in mediating agonist-induced confor­
mational changes required for G-protein activation [31]. In
the point mutation is reached. Then either translocation and/or 
translation are aborted. Correct translation and translocation of 
the intact protein followed by removal o f the C-terminal part, 
due to increased susceptibility of the mutant to proteolysis, is less 
likely because (1) no trace of the intact protein is detectable and 
(2) the point mutation resides within transmembrane domain VII 
and is not expected to strongly change proteolytic sensitivity 
outside that domain. Because Tyr-301 is highly conserved in the 
G-protein-coupled receptor family, we propose that it is essential 
for proper translocation and folding of the protein. Our ob­
servation that mutations at positions 299, 300 and 303 arc quite 
‘harmless’ in this respect (sec above) again shows how delicately 
tuned these functions are.
The situation for R69H is quite different. This mutant mainly 
produces an approx. 22 kDa truncated protein, which is 
glycosylated and still contains the e2 loop. It is currently unclear 
why translation and/or translocation are aborted shortly after 
the e2 loop by a mutation in the il loop. Although the complete 
protein is detectable in very small amounts, this probably 
indicates that a minor part of the translational events proceed to 
the intact protein. The alternative, complete translation to the 
intact protein followed by intracellular proteolysis is highly 
unlikely in our opinion because the required cleavage near the C~ 
terminus and/or in the i3 loop would result in products of 
approx. 33 kDa or approx. 26 and 13 kDa respectively [44]. 
Fragments smaller than 20 kDa were never observed. In addition, 
we did not observe larger amounts of intact protein at earlier 
time points (1 or 2 dpi).
Type C :  amino acid substitutions that affect membrane 
translocation and glycosylation
contrast, substitution of the corresponding Pro by Ser in the /i2- Substitutions at the positions Glu-113, Glu-122, Glu-134, Arg-
adrenergic receptor seemed to affect post-translational processing 
(non-glycosylated and partly glycosylated forms) [32]. It is
135 and Lys-248 belong to this category. We had already 
suggested that the charged pair Glu~134 and Arg-135 could be
important to note that this mutant contains two additional part of a stop-transfer site [18]. The mutations in transmembrane
mutations (A299C and V300A), which represent unconserved 
residues and are adjacent to residue Y 301, which will be discussed 
below.
The relatively innocuous effect o f  these Pro mutations supports
domain (TM) 111 (positions 113, 122, 134 and 135) pertain to 
highly polar residues localized within the membrane or at the 
membrane interface. Protein transfer signals consist of a com­
bination o f polar and hydrophobic residues and probably require
other evidence indicating that the replacement of single Pro a specific three-dimensional arrangement, clear insight in whicJ-
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is still lacking [45]. We propose that these four positions are protein-coupled receptors [31,42]. Replacement oi this residue 
important elements for a transfer signal, which in wild-type opsin with one lacking a negative charge leads to constitutive activity 
functions as a transfer stop, thereby positioning TM III in the in visual pigments, suggesting that it helps to constrain opsin into
membrane. When point mutations decrease the affinity of the 
signal site for the translocation machinery, there is a chance that 
it is not recognized as such and the signal ‘slips’ through. In that 
case TM Ili is fully translocated and translocation stops only at 
the next signal in TM IV, which in wild-type opsin functions as 
a start-transfer signal (transfer signals can probably function as 
both stop- and start-transfer sites, depending on the current 
activity of the translocase [45,46]). Hence, if a slip in the TM
an inactive conformation via a charge-pair interaction [54,56],
Type D : amino acid substitutions that produce an intact protein 
without detectable non-glycosylated product but lead to 
heterogeneous distribution in the plasma membrane and 
decreased regeneration
The mutations E113Q/D, W265F and Y268S belong to this
signal occurs, TM III and loop i2 are translocated and the rest of category. Immunohistochemical analysis oi these mutants
the topography of opsin reverses, the C-terminus finally being produces a patchy distribution in the plasma membrane. They
located extracellularly. This model would explain the partial have a strongly decreased regeneration capacity [16,22,34,35,37]
accessibility of these mutants to 1D4 and thermolysin in intact and the respective residues reportedly all interact with the retinal
cells. Interestingly, the chance of such a slip’s occurring clearly chromophore in bovine rhodopsin [35]. The structural effects of
depends on the type of substitution (E134R-R135E >  E134R > the El 13Q mutation, which among others result in constitutive
E134D; El 13Y > El 13D > El 13Q). This suggests that in wild- activity [54,56], might lead to lower stability, an enhanced 
type opsin the signal is very delicately tuned.
A similar model can be put forward for the K248L mutant.
tendency to aggregate and a decrease in regeneration capacity. 
Mutation of Trp-265 might also induce structural changes, as
Lys-248 is located in the interface region of TM VI. If replacement evident from lower regeneration capacity, a blue shift of
of the polar Lys-248 with the apolar Leu interferes with the 
proper functioning of the start-transfer signal in TM VI, this 
signal might ‘slip through’. TM VI and loop e3 will not be 
translocated and the signal in TM VII will induce transfer start, 
again with extracellular location of the C-terminal as a result.
Hence our results can be explained by assuming that the type 
C mutations interfere with the function o f a transfer signal, 
resulting in a significant ‘slip’ o f the signal. It should be further 
noted that in all positions in this category (E113C, E122L, 
E134D, K248L; Table 3) the non-glycosylated forms are less 
susceptible to proteolysis in intact cells than the glycosylated 
forms but are rapidly proteolysed in lysed cells. Our interpretation 
is that these non-glycosylated species have not been targeted to 
the plasma membrane but, probably because of folding problems, 
became stuck in traffic, possibly in the endoplasmic reticulum. 
We are currently trying to locate these intracellular species more 
precisely by confocal microscopy.
Although the effect of mutations on folding and targeting has 
not been reported in much detail in the literature, scattered 
results generally support our model. First, the extracellular 
domain is very sensitive to point mutations and deletions. These 
usually lead to incorrect folding and loss o f glycosylation 
[4,47-52], indicating that the structural organization of this 
domain is easily perturbed and that glycosylation is sensitive to 
the structure of this entire domain. Furthermore the mutation 
R135L/W is found in patients with autosomal dominant retinitis 
pigmentosa [50,53] and seems to be associated with glycosylation 
and targeting [50]. Mutation of Glu-113 to Lys also resulted in 
misfolding and impaired glycosylation [16,54]. This is also 
described for the mutant E122K [16].
It should be emphasized that, when correctly folded and 
glycosylated, these mutant opsins do generate a corresponding 
photopigment [22]. An interesting phenomenon, however, is that 
all of these mutant pigments are also affected with respect to 
signal transduction. The effects vary from a complete loss of 
transducin activation (R135Q/W/L) [16,17,50,53] to a decrease 
(E122Q/D/A, E134D, K248L) [16,17,35,55], Several mutants in 
these positions show constitutive activity (El 13Q [54,56]; E134A 
[36]). In most other G-protein-coupled receptors an Asp residue 
at the position corresponding to Glu-134 is fully conserved and 
seems to be required for efficient signal transduction [31,42]. 
Residue Lys-248 also seems to be of similarly general importance 
[57,58]. Glu-113 is considered to be the Schiff base counterion in 
visual pigments [16,34,37] and a ligand counterion in several G-
20-30 nm and a decrease in transducin activation [35]. In the m3 
receptor, decreased affinities for both agonists and antagonists 
are observed on mutation of this residue. Hence this residue 
probably contributes to stabilizing the ligand-receptor complex
[31]-
Evidence is also available for structural perturbation in Tyr- 
268 mutants. The mutation Y268F in rhodopsin decreases 
transducin activation [35] and in the m3 receptor leads to 
decreased ligand-binding affinities [31].
Conclusions
In conclusion, we can state that single substitution of amino 
acids in the opsin sequence generally affects a combination o f  
structural and/or functional properties. This again emphasizes 
that structure and function of this G-protein-coupled receptor 
are intimately related and delicately tuned. In addition, in view 
of the delicate tuning of the opsin sequence towards correct 
translocation and folding it can be expected that these functions 
are easily perturbed by single mutations. Hence we do not 
consider it remarkable that a large number of point mutations 
in rhodopsin are connected to autosomal dominant retinitis 
pigmentosa.
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